Similar Search Results

Disease Management: Maximising Treatment Adherence and Self-Management

Todd, Warren E.; Ladon, Edward H. - In: Disease Management and Health Outcomes 3 (1998) 1, pp. 1-10

The effective management of chronic illness has historically been plagued by patient non-adherence to treatment regimens. While disease management initiatives have recently proliferated in an attempt to more effectively manage these chronic illnesses, many of these new programmes have lacked...

Persistent link: https://www.econbiz.de/10005404629

Management of Rheumatoid Arthritis: Defining the Role of Etanercept

Keating, Gillian M.; Jarvis, Blair - In: Disease Management and Health Outcomes 10 (2002) 1, pp. 17-39

Rheumatoid arthritis is associated with substantial costs to both the individual and society; costs increase as disease severity worsens. Current thinking is that disease-modifying antirheumatic drug (DMARD) therapy should be started as soon as possible after the diagnosis of rheumatoid...

Persistent link: https://www.econbiz.de/10005404630

Enhancing Outcomes Research: The Experience of a Community Pharmacist Research Network

Longe, R. Leon; Taylor, A. Thomas; Wade, William E.; … - In: Disease Management and Health Outcomes 6 (1999) 5, pp. 261-268

The emphasis on healthcare in the US is shifting to the ambulatory environment. To date, few studies have evaluated the effects that community pharmacists have on patient care. In an attempt to address this issue, 4 academicians from a college of pharmacy developed a research network of...

Persistent link: https://www.econbiz.de/10005404631

Pulmonary Rehabilitation Programs: Outcomes in Patients with Chronic Obstructive Pulmonary Disease

Ambrosino, Nicolino - In: Disease Management and Health Outcomes 10 (2002) 9, pp. 535-542

decrease in healthcare usage. Pulmonary rehabilitation is effective in all settings including hospital inpatient, hospital …

Persistent link: https://www.econbiz.de/10005404632

Active Management of Patients with Chronic Renal Insufficiency: The Effect on Hospital Days During the Initial Hemodialysis Period

Zawadzki, Ilan; Fridman, Moshe; Chan, Wing; Ryu, Seonyoung - In: Disease Management and Health Outcomes 11 (2003) 4, pp. 249-258

-dialysis patient care on hospital days during the 6 months after hemodialysis initiation. Study Design: Data were obtained from Group … patient spent in hospital during the baseline (1 year to 6 months pre-dialysis), pre-dialysis (180 days pre-dialysis), and … post-dialysis initiation (180 days following dialysis initiation) periods were recorded. Hospital days during the post …

Persistent link: https://www.econbiz.de/10005404633

Pharmacy Benefit Managers' Role in Facilitating Medicare Beneficiary Access to Pharmaceutical Care

Cohen, Joshua; Chee, Jennifer - In: Disease Management and Health Outcomes 10 (2002) 4, pp. 221-227

This paper assesses the role that pharmacy benefit managers (PBMs) could play in facilitating improved Medicare beneficiary access to pharmaceutical care (which includes access to pharmaceuticals as well as disease management coverage). Based on a literature review and original survey results,...

Persistent link: https://www.econbiz.de/10005404634

Effectiveness of a Structured Intensive Weight Loss Program Using Health Educators

Rohrer, James E.; Cassidy, Harvey D.; Dressel, Diane; … - In: Disease Management and Health Outcomes 16 (2008) 6, pp. 449-454

Background: Primary care providers may refer their patients to a variety of weight loss programs and diet plans. However, the relative effectiveness of the available options is not well understood. This retrospective study compared weight loss in an intensive structured (IS) program using health...

Persistent link: https://www.econbiz.de/10005404635

Playing Disease Management Numbers Games

Stone, Robert E. - In: Disease Management and Health Outcomes 6 (1999) 6, pp. 343-348

Many health plans and providers rely on return on investment (ROI) to determine the value of a disease management programme. ROI, however, is not the most meaningful measure of the true value of a programme. Depending on the methods used to calculate costs and determine the size of the...

Persistent link: https://www.econbiz.de/10005404636

Disease Management Update

Adis International Limited - In: Disease Management and Health Outcomes 10 (2002) 2, pp. 137-140

Persistent link: https://www.econbiz.de/10005404637

Prescription to Over-the-Counter Switch of Second-Generation Antihistamines (Loratadine): A Review of Its Impact on Healthcare Costs and Resource Utilization

Nair, Kavita V. - In: Disease Management and Health Outcomes 14 (2006) 2, pp. 69-74

The over-the-counter (OTC) conversion of loratadine was approved in the US in December 2002 for the treatment of allergic rhinitis, representing the first second-generation antihistamine (SGA) to be made available as an OTC product. This review examines the current evidence regarding the impact...

Persistent link: https://www.econbiz.de/10005404638